No Data
No Data
Express News | Maxim Group Initiates Coverage On Mainz Biomed With Buy Rating, Announces Price Target of $14
Maxim Group Keeps Their Buy Rating on Research Solutions (RSSS)
Maxim Starts Mainz Biomed at Buy on CRC Screening Potential
Nutex Health Price Target Raised to $75.00/Share From $50.00 by Maxim Group
NeoVolta (NEOV) Receives a Buy From Maxim Group
Public Housing Receives RM185 Million For Upgrading
Unlock the Full List